http://polarispharma.com/wp-content/uploads/Polaris_Logo_FullColor_Old-350x96-350x96.png
0
0
MaxDing
http://polarispharma.com/wp-content/uploads/Polaris_Logo_FullColor_Old-350x96-350x96.png
MaxDing2021-03-04 00:20:552021-03-18 17:29:11Polaris Phase III interim analysis of lung mesothelioma carcinoma showed a statistically significant overall survival rate of 80% or higher for the highest grade.
http://polarispharma.com/wp-content/uploads/Polaris_Logo_FullColor_Old-350x96-350x96.png
0
0
MaxDing
http://polarispharma.com/wp-content/uploads/Polaris_Logo_FullColor_Old-350x96-350x96.png
MaxDing2020-10-06 00:00:002020-10-07 20:36:14Polaris Group signs collaboration agreement with Nanotein Technologies, Inc.
http://polarispharma.com/wp-content/uploads/Polaris_Logo_FullColor_Old-350x96-350x96.png
0
0
MaxDing
http://polarispharma.com/wp-content/uploads/Polaris_Logo_FullColor_Old-350x96-350x96.png
MaxDing2020-09-17 09:00:312020-10-07 20:38:38Polaris announces to enroll the first patient of Phase IB Clinical Trial in GBM
http://polarispharma.com/wp-content/uploads/Polaris_Logo_FullColor_Old-350x96-350x96.png
0
0
MaxDing
http://polarispharma.com/wp-content/uploads/Polaris_Logo_FullColor_Old-350x96-350x96.png
MaxDing2019-12-17 17:47:412019-12-17 22:22:55Polaris Group Announces officially secured USD $100 million new funding
http://polarispharma.com/wp-content/uploads/Polaris_Logo_FullColor_Old-350x96-350x96.png
0
0
MaxDing
http://polarispharma.com/wp-content/uploads/Polaris_Logo_FullColor_Old-350x96-350x96.png
MaxDing2019-12-10 18:36:392019-12-10 18:36:39Polaris Group ADI-PEG20 on the cover of AACR journals
http://polarispharma.com/wp-content/uploads/Polaris_Logo_FullColor_Old-350x96-350x96.png
0
0
Polarispharma
http://polarispharma.com/wp-content/uploads/Polaris_Logo_FullColor_Old-350x96-350x96.png
Polarispharma2019-02-22 00:00:522019-03-18 15:47:42Polaris Group Announces Dr. Shaw Chen as New Interim CEO
http://polarispharma.com/wp-content/uploads/Polaris_Logo_FullColor_Old-350x96-350x96.png
0
0
Polarispharma
http://polarispharma.com/wp-content/uploads/Polaris_Logo_FullColor_Old-350x96-350x96.png
Polarispharma2019-02-22 00:00:092019-03-18 15:52:54Polaris Group Announces Wayne Lin as New COO
http://polarispharma.com/wp-content/uploads/Polaris_Logo_FullColor_Old-350x96-350x96.png
0
0
Polarispharma
http://polarispharma.com/wp-content/uploads/Polaris_Logo_FullColor_Old-350x96-350x96.png
Polarispharma2018-07-09 00:01:182018-07-09 12:25:42Polaris Announces Dr. Chi Van Dang Joining its Scientific Advisory Board
http://polarispharma.com/wp-content/uploads/Polaris_Logo_FullColor_Old-350x96-350x96.png
0
0
Polarispharma
http://polarispharma.com/wp-content/uploads/Polaris_Logo_FullColor_Old-350x96-350x96.png
Polarispharma2018-07-08 00:01:382018-07-09 12:25:23Polaris Announces Drs. James Allison and Padmanee Sharma Joining its Scientific Advisory Board
http://polarispharma.com/wp-content/uploads/Polaris_Logo_FullColor_Old-350x96-350x96.png
0
0
Polarispharma
http://polarispharma.com/wp-content/uploads/Polaris_Logo_FullColor_Old-350x96-350x96.png
Polarispharma2018-06-06 15:29:142018-06-06 15:29:14Polaris Group Announces Results of a Phase 1 Clinical Study with its Lead Therapeutic Candidate ADI‑PEG 20 in Metastatic Uveal Melanomas